Welcome to our dedicated page for Lloyds Banking SEC filings (Ticker: LYG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lloyds Banking's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lloyds Banking's regulatory disclosures and financial reporting.
Lloyds Banking Group plc reported daily activity under its existing share buyback programme. On 13 November 2025, the company purchased 9,995,770 ordinary shares from its broker, with a volume‑weighted average price of 94.9738 pence. The highest price paid was 95.6800 pence and the lowest was 94.2000 pence.
The company stated it intends to cancel these shares, which reduces the share count once completed. The purchases were executed pursuant to instructions issued on 20 February 2025 and announced on 21 February 2025. A trade-by-trade breakdown is available via the linked schedule.
Lloyds Banking Group reported purchases of 9,926,197 ordinary shares on 12 November 2025 as part of its existing share buyback programme and stated it intends to cancel these shares. The trades were executed by Morgan Stanley & Co. International plc.
Prices ranged from a lowest 94.6200 pence to a highest 95.5000 pence, with a volume‑weighted average price of 95.2302 pence. The company referenced a schedule of individual trades available via the London Stock Exchange link in the announcement.
Lloyds Banking Group plc reported a routine share buyback transaction. On 11 November 2025, the company purchased 10,094,833 ordinary shares from Morgan Stanley & Co. International plc. Prices ranged from 93.5000p to 95.0000p, with a volume-weighted average price of 94.4983p per share. These repurchases form part of the existing buyback programme initiated in February 2025, and the company intends to cancel the purchased shares.
Lloyds Banking Group plc reported routine PDMR dealings tied to its Share Incentive Plan. On 10 November 2025, several senior executives acquired Partnership Shares and received Matching Shares in ordinary shares of 10 pence each.
Examples include: Kate Cheetham (Chief Legal Officer and Company Secretary) acquired 165 Partnership Shares at GBP00.9060 and received 49 Matching Shares; Stephen Shelley (Chief Risk Officer) acquired 166 at GBP00.9060 and received 49 Matching Shares. Transactions were recorded as occurring outside a trading venue. The instrument is Ordinary Shares (ISIN GB0008706128).
Lloyds Banking Group plc reported a routine buyback execution. On 10 November 2025, the company purchased 10,312,855 ordinary shares from Morgan Stanley & Co. International plc as part of its existing share buyback programme. The price ranged from 91.34p to 92.90p per share, with a volume-weighted average price of 92.1656p. The company intends to cancel these shares. The programme follows instructions issued on 20 February 2025 and announced on 21 February 2025.
Lloyds Banking Group reported a routine share repurchase under its existing buyback programme. On 07 November 2025, the company bought 10,442,135 ordinary shares from Morgan Stanley & Co. International plc. The volume‑weighted average price was 91.1403 pence, within a 90.4200–92.0000 pence range. The company intends to cancel these shares, reducing the share count once cancelled. A trade‑by‑trade breakdown is available via the linked schedule.
Lloyds Banking Group plc reported transactions in own securities. The Company purchased 26,446,044 ordinary shares on 06 November 2025 through Morgan Stanley & Co. International plc as part of its existing share buyback programme. The volume weighted average price paid per share was 91.3997 pence, with a highest price of 91.8800 pence and a lowest price of 90.9200 pence.
These purchases were effected pursuant to instructions issued on 20 February 2025 and announced on 21 February 2025. The Company intends to cancel the repurchased shares. A full breakdown of individual trades is available via the schedule linked in the announcement.
Lloyds Banking Group plc reported a PDMR share transaction. Andrew Walton, the Group’s Chief Sustainability Officer and Chief Corporate Affairs Officer, sold 122,495 ordinary shares on 5 November 2025 at 88.80 pence per share on the London Stock Exchange. The company noted that, following this sale, he continues to comply with the Group’s shareholding policy requirements.
Lloyds Banking Group plc reported a routine share repurchase under its existing buyback programme. On 05 November 2025, the company bought 8,975,424 ordinary shares from Morgan Stanley & Co. International plc for cancellation.
The volume‑weighted average price was 88.9705 pence, with a daily range of 88.4800–89.4800 pence. The company stated it intends to cancel these shares, reducing the share count in line with previously announced instructions issued on 20 February 2025.
Lloyds Banking Group plc filed a Form 6‑K to incorporate documents related to a multi‑tranche U.S. dollar senior note issuance. The company issued $1,500,000,000 aggregate principal amount of 4.425% Senior Callable Fixed‑to‑Fixed Rate Notes due 2031, $1,250,000,000 aggregate principal amount of 4.943% Senior Callable Fixed‑to‑Fixed Rate Notes due 2036, and $300,000,000 aggregate principal amount of Senior Callable Floating Rate Notes due 2031.
The filing adds a supplemental indenture and legal opinions to the company’s automatic shelf registration (Form F‑3ASR). Exhibits include the Twenty‑Second Supplemental Indenture and opinions from CMS Cameron McKenna Nabarro Olswang LLP and Davis Polk & Wardwell London LLP.